ALDER BIOPHARMACEUTICALS INC 4
4 · ALDER BIOPHARMACEUTICALS INC · Filed Jun 16, 2015
Insider Transaction Report
Form 4
Benedict Larry
Sr. VP Finance
Transactions
- Sale
Common Stock
2015-06-12$47.46/sh−25,454$1,208,090→ 1,266 total - Exercise/Conversion
Common Stock
2015-06-12$1.65/sh+25,454$41,999→ 26,720 total - Exercise/Conversion
Stock Option (Right to Buy)
2015-06-12−25,454→ 0 totalExercise: $1.65Exp: 2018-07-22→ Common Stock (25,454 underlying)
Footnotes (3)
- [F1]Includes 603 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on May 29, 2015.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.30 to $47.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2 to this Form 4.
- [F3]The option is fully vested.